Pronounced benefit of Paxlovid in hospitalized patients out to year vs #LongCovid sequelae, including survival www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00217-2/fulltext @TheLancetInfDis More pronounced for age 65+ and those with 3-dose vaccination. Graph at right is post 21-day mortality pic.twitter.com/GL7ZoNPTfZ

A 2-year #LongCovid prospective study in Norway "A positive #SARSCoV2 test was associated with new onset memory- and concentration problems, anosmia and dysgeusia, dyspnoea and fatigue as well as self-assessed worsening of overall health, which persisted for the length of the…

Routine #immunization is a lifesaver. Ensuring equitable access means no one is left vulnerable to preventable diseases. Yes, #VaccinesWork! pic.twitter.com/hvlzd3FwgA

From the Conference of Retroviruses & Opportunistic Infections: persistence of Covid in megakaryocytes in #LongCovid. Over my head, but my understanding: megakaryocytes (type of bone marrow cell) being infected = continuous infection, very serious! www.croiconference.org/wp-content/uploads/sites/2/posters/2024/347.pdf 1/ pic.twitter.com/WIjipqTHUW